A detailed history of Life Pro Asset Management transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Life Pro Asset Management holds 10,410 shares of ANIX stock, worth $34,977. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,410
Previous 10,760 3.25%
Holding current value
$34,977
Previous $23,000 39.13%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$2.21 - $3.48 $773 - $1,218
-350 Reduced 3.25%
10,410 $32,000
Q2 2024

Jul 10, 2024

BUY
$2.21 - $3.35 $23,779 - $36,046
10,760 New
10,760 $23,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $103M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Life Pro Asset Management Portfolio

Follow Life Pro Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Life Pro Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Life Pro Asset Management with notifications on news.